Calcaneal ultrasound bone densitometry is not a useful tool to screen patients with inflammatory bowel disease at high risk for metabolic bone disease

Inflammatory Bowel Diseases

Volumn 11, Issue 8, 2005, Pages 749-754

  Schwartz, David A ^a   Connolley, Chris D ^a   Koyama, Tatsuki ^a   Wise, Paul E ^a   Herline, Alan J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcaneal ultrasound bone densitometry; Inflammatory bowel disease; Osteopenia; Osteoporosis

Indexed keywords

ADULT; ARTICLE; BONE DENSITOMETRY; CALCANEUS; DIAGNOSTIC VALUE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC BONE DISEASE; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK BENEFIT ANALYSIS; ULTRASOUND;

ADULT; AGE DISTRIBUTION; BONE DENSITY; BONE DISEASES, METABOLIC; CALCANEUS; COHORT STUDIES; COMORBIDITY; DENSITOMETRY; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MASS SCREENING; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; ULTRASONOGRAPHY, DOPPLER;

EID: 24644520681     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000172809.11501.f4     Document Type: Article

References (42)

1. Looker AC, Orwoll ES, Johnston CC, Jr., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761-1768.
2. Melton LJ 3rd, Chrischilles EA, Cooper C, et al. Perspective. How many women have osteoporosis? J Bone Miner Res. 1992;7:1005-1010.
3. Kirchgatterer A, Wenzl HH, Aschl G, et al. Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: recommendations and reality. Acta Med Austriaca. 2002;29:120-123.
4. Schoon EJ, van Nunen AB, Wouters RS, et al. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol Suppl. 2000;232:43-47.
5. Schulte C, Dignass AU, Mann K, et al. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:268-275.
6. Pollak RD, Karmeli F, Eliakim R, et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93:1483-1490.
7. Haugeberg G, Vetvik K, Stallemo A, et al. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study. Scand J Gastroenterol. 2001;36:759-765.
8. Robinson RJ, al-Azzawi F, Iqbal SJ, et al. Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci. 1998;43: 2500-2506.
9. Abitbol V, Roux C, Chaussade S. et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 1995;108: 417-422.
10. Silvennoinen JA, Karttunen TJ, Niemela SE, et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995;37:71-76.
11. Silvennoinen J, Lamberg-Allardt C, Karkkainen M, et al. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med. 1996;240:285-292.
12. Jahnsen J, Falch JA, Mowinckel P, et al. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192-199.
13. Roggia C, Tamone C, Cenci S, et al. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med. 2004;95:125-132.
14. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone. 2002;30:340-346.
15. Lee WY, Baek KH, Rhee EJ, et al. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant. 2004;34:89-94.
16. Abreu M, Canalis E, Kane S, et al. Osteoporosis and Inflammatory Bowel Disease: A Guide to Diagnosis and Management for the Gastroenterologist. American College of Gastroenterology; 2002.
17. Papaioannou A, Ferko NC, Adachi JD. All patients with inflammatory bowel disease should have bone density assessment: pro. Inflamm Bowel Dis. 2001;7:158-162.
18. Valentine JF, Sninsky CA. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol. 1999;94: 878-883.
19. Hans D, Arlot ME, Schott AM, et al. Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass?: a two-dimensional histomorphometric study. Bone. 1995;16:295-300.
20. Gluer CC, Wu CY, Genant HK. Broadband ultrasound attenuation signals depend on trabecular orientation: an in vitro study. Osteoporos Int. 1993;3:185-191.
21. Gluer CC, Wu CY, Jergas M, et al. Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int. 1994;55:46-52.
22. Greenspan SL, Cheng S, Miller PD, et al. Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int. 2001;12: 391-398.
23. Greenspan SL, Bouxsein ML, Melton ME, et al. Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res. 1997;12:1303-1313.
24. Mughal MZ, Ward K, Qayyum N, et al. Assessment of bone status using the contact ultrasound bone analyser. Arch Dis Child. 1997;76:535-536.
25. Fries W, Dinca M, Luisetto G, et al. Calcaneal ultrasound bone densitometry in inflammatory bowel disease-a comparison with double x-ray densitometry of the lumbar spine. Am J Gastroenterol. 1998;93: 2339-2344.
26. Jahnsen J, Falch JA, Mowinckel P, et al. Ultrasound measurements of calcaneus for estimation of skeletal status in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:790-797.
27. Javaid MK, McCrudden PR, Taylor P, et al. Comparison of calcaneal ultrasound and DXA to assess the risk of corticosteroid-induced osteoporosis: a cross-sectional study. Osteoporos Int. 2001;12:788-793.
28. Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res. 1995;10:250-256.
29. Pigot F, Roux C, Chaussade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci. 1992;37:1396-1403.
30. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987;28:410-415.
31. Altman D, Bland J. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32:307-317.
32. Hartl F, Tyndall A, Kraenzlin M, et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the Basel Osteoporosis Study. J Bone Miner Res. 2002;17:321-330.
33. Haugeberg G, RE OR, Uhlig T, et al. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporos Int. 2003;14:312-319.
34. Orstavik RE, Haugeberg G, Uhlig T, et al. Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities. Ann Rheum Dis. 2004;63:945-951.
35. Bjarnason I, Macpherson A, Mackintosh C, et al. Reduced bone density in patients with inflammatory bowel disease. Gut. 1997;40:228-233.
36. Tobias JH, Sasi MR, Greenwood R, et al. Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy. Aliment Pharmacol Ther. 2004;20:951-957.
37. Davis JW, Ross PD, Wasnich RD, et al. Comparison of cross-sectional and longitudinal measurements of age-related changes in bone mineral content. J Bone Miner Res. 1989;4:351-357.
38. Marshall D, Johneil O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-1259.
39. Jahnsen J, Falch JA, Aadland E, et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut. 1997;40:313-319.
40. Stockbrugger RW, Schoon EJ, Bollani S, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther. 2002;16:1519-1527.
41. Lee SH, Kim HJ, Yank SK, et al. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol. 2000;15:512-518.
42. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12: 519-528.